deltatrials
Approved For Marketing EXPANDED_ACCESS NCT03906331

Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation

Sponsor: Eli Lilly and Company

Conditions Breast Cancer Colon Cancer Medullary Thyroid Cancer Non Small Cell Lung Cancer Other Solid Tumors With Evidence of Activating RET Alteration Pancreatic Cancer Papillary Thyroid Cancer
Interventions Selpercatinib
Updated 43 times since 2019 Last updated: Jan 16, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Breast Cancer and Colon Cancer, this trial is ongoing. The trial is conducted by Eli Lilly and Company and has accumulated 43 data snapshots since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~May 2019 – ~Nov 2019 · 6 months · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Mar 2020 · 2 months · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Mar 2021 · 28 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Jun 2021 · 31 days · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshot~Feb 2022 – ~Mar 2022 · 28 days · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Jun 2022 · 31 days · monthly snapshot~Jun 2022 – ~Jul 2022 · 30 days · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshot~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshot~Mar 2023 – ~Apr 2023 · 31 days · monthly snapshot~Apr 2023 – ~May 2023 · 30 days · monthly snapshot~May 2023 – ~Jun 2023 · 31 days · monthly snapshot~Jun 2023 – ~Aug 2023 · 2 months · monthly snapshot~Aug 2023 – ~Oct 2023 · 2 months · monthly snapshot~Oct 2023 – ~Nov 2023 · 31 days · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Jan 2025 · 2 months · monthly snapshot~Jan 2025 – ~Feb 2025 · 31 days · monthly snapshot~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshot~Sep 2025 – present · 9 months · monthly snapshot

Change History

43 versions recorded

  1. Sep 2025 — Present [monthly]

    Approved For Marketing

  2. Feb 2025 — Sep 2025 [monthly]

    Approved For Marketing

  3. Jan 2025 — Feb 2025 [monthly]

    Approved For Marketing

    Status: Available → Approved For Marketing

  4. Nov 2024 — Jan 2025 [monthly]

    Available

  5. Sep 2024 — Nov 2024 [monthly]

    Available

▶ Show 38 earlier versions

  1. Jul 2024 — Sep 2024 [monthly]

    Available

  2. Nov 2023 — Jul 2024 [monthly]

    Available

  3. Oct 2023 — Nov 2023 [monthly]

    Available

  4. Aug 2023 — Oct 2023 [monthly]

    Available

  5. Jun 2023 — Aug 2023 [monthly]

    Available

  6. May 2023 — Jun 2023 [monthly]

    Available

  7. Apr 2023 — May 2023 [monthly]

    Available

  8. Mar 2023 — Apr 2023 [monthly]

    Available

  9. Feb 2023 — Mar 2023 [monthly]

    Available

  10. Jan 2023 — Feb 2023 [monthly]

    Available

  11. Dec 2022 — Jan 2023 [monthly]

    Available

  12. Nov 2022 — Dec 2022 [monthly]

    Available

  13. Sep 2022 — Nov 2022 [monthly]

    Available

  14. Jul 2022 — Sep 2022 [monthly]

    Available

  15. Jun 2022 — Jul 2022 [monthly]

    Available

  16. May 2022 — Jun 2022 [monthly]

    Available

  17. Apr 2022 — May 2022 [monthly]

    Available

  18. Mar 2022 — Apr 2022 [monthly]

    Available

  19. Feb 2022 — Mar 2022 [monthly]

    Available

  20. Jan 2022 — Feb 2022 [monthly]

    Available

  21. Dec 2021 — Jan 2022 [monthly]

    Available

  22. Nov 2021 — Dec 2021 [monthly]

    Available

  23. Oct 2021 — Nov 2021 [monthly]

    Available

  24. Sep 2021 — Oct 2021 [monthly]

    Available

  25. Jun 2021 — Sep 2021 [monthly]

    Available

  26. May 2021 — Jun 2021 [monthly]

    Available

    Status: Temporarily Not Available → Available

  27. Apr 2021 — May 2021 [monthly]

    Temporarily Not Available

  28. Mar 2021 — Apr 2021 [monthly]

    Temporarily Not Available

  29. Feb 2021 — Mar 2021 [monthly]

    Temporarily Not Available

    Status: Available → Temporarily Not Available

  30. Jan 2021 — Feb 2021 [monthly]

    Available

  31. Jun 2020 — Jan 2021 [monthly]

    Available

  32. May 2020 — Jun 2020 [monthly]

    Available

  33. Apr 2020 — May 2020 [monthly]

    Available

  34. Mar 2020 — Apr 2020 [monthly]

    Available

  35. Jan 2020 — Mar 2020 [monthly]

    Available

  36. Dec 2019 — Jan 2020 [monthly]

    Available

  37. Nov 2019 — Dec 2019 [monthly]

    Available

  38. May 2019 — Nov 2019 [monthly]

    Available

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eli Lilly and Company
Data source: Eli Lilly and Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Athens, United States , Atlanta, United States , Auckland, New Zealand , Barcelona, Spain , Beersheba, Israel , Berlin, Germany , Bordeaux, France , Boston, United States , Camperdown, Australia and 51 more locations